This announcement is a separate document:
亚太药业：关于公司注射用头孢唑肟钠增加规格并通过仿制药一致性评价的公告
Zhejiang Yatai Pharmaceutical: Announcement regarding the increase in specification of the company's injection of Cefozopran Sodium and the approval of generic consistency evaluation.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.